Students living with cystic fibrosis (CF) and attending or starting college, either at the undergraduate or graduate level, are invited…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Cystic Fibrosis Canada has opened an initiative called Elevate, inviting people affected by cystic…
A research ethics committee in Australia has given Krystal Biotech the go-ahead to start a Phase 1 clinical study…
The publicly funded drug access programs in the Canadian provinces of Alberta and Saskatchewan are now covering the triple-combination therapy …
People with cystic fibrosis (CF) in Ontario, Canada, will now have access to the triple-combination therapy Trikafta through the…
A two-day virtual event called BreatheCon will offer adults with cystic fibrosis (CF) an opportunity to connect and share…
Increasing the levels of the SFPQÂ protein helped to restore expression and function of the CFTR protein in cells with a…
A new study is seeking to understand whether and how the symptoms of cystic fibrosis (CF) are affected…
The U.S. Food and Drug Administration (FDA) has given fast track designation to ELX-02, an investigational treatment for people with …
The Centers for Medicare and Medicaid Services (CMS) has published a local coverage determination confirming that Relizorb…